Our local DOT drug and alcohol testing centers are located in Tate GA and the surrounding areas providing DOT drug testing, DOT alcohol testing and DOT physicals for all DOT modes regulated by Part 40. Same day service is available at our Tate GA DOT drug testing facilities and most of our DOT drug testing locations are within minutes of your home or office.
What type of DOT Testing is required?
Coastal Drug Testing provides DOT pre-employment, random, post-accident, reasonable suspicion and return to duty testing at our Tate GA DOT drug testing centers.
If you hold a CDL license, a large, medium or a small trucking company, Coastal Drug Testing has a complete DOT compliance package which includes all the requirements to comply with CFR 49 part 40.
All Coastal Drug Testing DOT drug testing centers utilize SAMHSA Certified laboratories and a licensed Medical Review Officer as required by DOT part 40 regulations.
The U.S Department of Transportation (DOT) requires that all DOT regulated "safety sensitive" employees have a negative DOT pre-employment drug test result on file and be actively enrolled in a DOT approved random drug and alcohol random testing pool (consortium).
In addition, if a DOT regulated company has more than one "safety sensitive" employee, the employer must also have a written DOT drug and alcohol policy along with an on-site supervisor that must have completed a reasonable suspicion supervisor training program.
On the road and need a DOT Drug or Alcohol test? No Worries!
To be compliant with DOT regulations, a company's DOT drug and alcohol testing program must have the following components:
- Employee Drug Testing
- Written Drug and Alcohol Policy
- Supervisor Training
- Substance Abuse Referral
- Employee Education
- Random Selection Program
- Post Accident Testing
- Designated Employer Representative
- Federal Chain of Custody Forms
- Part 40 Regulations on File
The Department of Transportation (DOT) has specific drug and alcohol testing requirements for the all transportation modes all DOT agencies.
Our modes included are:
- Federal Motor Carrier Safety Administration (FMCSA)
- Federal Aviation Administration (FAA)
- Federal Transit Administration (FTA)
- United States Coast Guard (USCG)
- Pipeline and Hazardous Materials Safety Administration (PHMSA)
- Federal Railroad Administration (FRA)
Are You Enrolled in a DOT Consortium?
Individuals who are employed in a position designated as "safety sensitive" must be actively enrolled in a random drug and alcohol testing program. Oftentimes, covered employees will join a group of other DOT regulated employees in a random testing program and this is referred to as a DOT Consortium. Generally, an employer who has less than fifty employees or single operators will join the consortium which will comply with the random drug and alcohol testing requirements of 49 CFR Part 40. Employers that have over 50 employees who are regulated by Part 40 may elect to be enrolled in a "stand alone" random testing pool.
The DOT consortium is cost effective and complies with all requirements of 49 CFR Part 40 which mandates that all "safety sensitive" employees be enrolled in a random drug and alcohol testing program.
The Department of Transportation (DOT) has strict regulations requiring regulated companies and independent operators (CDL License Holders) to be an active member of a DOT drug and alcohol Consortium and failure to comply with these regulations can result in significant fines and other DOT sanctions.
We are fully versed in the DOT procedures for pre-employment drug testing, random drug testing, reasonable suspicion drug testing, post-accident drug testing, return to duty drug testing and follow up drug testing.
DOT regulated companies with multiple safety sensitive employees must also have an employee within the company who is assigned as the "designated employer representative" (DER). This is the person responsible for removing any DOT "safety sensitive" employee who is covered by 49 CFR Part 40 from performing a DOT safety sensitive position when a positive drug or alcohol test result has occurred or an employee has refused to take a required DOT test.
If you have recently become a DOT regulated company, within the next 18 months the Department of Transportation (DOT) will conduct a "new entrant" inspection to ensure that you are in compliance with all DOT regulations including the drug and alcohol testing requirements. If you are currently a DOT regulated company, you are subject to regular inspections to ensure compliance.
Avoid DOT fines, penalties and be complaint with all DOT drug and alcohol testing regulations! Coastal Drug Testing can assist small, medium and large DOT companies in complying with all requirements of 49 CFR Part 40.
DOT Drug Testing Locations in Tate GA
220 J L WHITE DR 4.0 miles
JASPER, GA 30143
1266 HIGHWAY 515 S 4.2 miles
JASPER, GA 30143
684 W CHURCH ST STE 200 4.7 miles
JASPER, GA 30143
14 SAMMY MCGHEE BLVD 5.0 miles
JASPER, GA 30143
5983 HIGHWAY 53 E STE 175 6.4 miles
DAWSONVILLE, GA 30534
201 HOSPITAL RD 13.5 miles
CANTON, GA 30114
81 NORTHSIDE DAWSON DR STE 205 13.6 miles
DAWSONVILLE, GA 30534
230 MARIETTA HWY STE 100 13.8 miles
CANTON, GA 30114
1030 MARIETTA RD 15.3 miles
CANTON, GA 30114
572 MADDOX DR STE 202B 18.8 miles
ELLIJAY, GA 30540
1362 S MAIN ST 19.2 miles
ELLIJAY, GA 30540
200 INDUSTRIAL BLVD STE 114 19.3 miles
ELLIJAY, GA 30540
260 ELM ST 19.9 miles
CUMMING, GA 30040
2825 KEITH BRIDGE RD 20.3 miles
CUMMING, GA 30041
5670 ATLANTA HWY STE C-1 20.4 miles
ALPHARETTA, GA 30004
108 PROMINENCE CT STE 200 20.4 miles
DAWSONVILLE, GA 30534
108 PROMINENCE CT STE 100 20.4 miles
DAWSONVILLE, GA 30534
1080 LUMPKIN CAMPGROUND RD S 20.6 miles
DAWSONVILLE, GA 30534
PO BOX 958 20.8 miles
WOODSTOCK, GA 30188
1330 Atlanta Hwy 21.1 miles
Cumming, GA 30040
2021 MARKET PLACE BLVD 21.4 miles
CUMMING, GA 30041
907 Buford Rd Ste 300 21.9 miles
Cumming, GA 30041
13081 HIGHWAY 9 N 22.2 miles
MILTON, GA 30004
12994 HIGHWAY 9 N 22.2 miles
MILTON, GA 30004
1432 TOWNELAKE PKWY STE 170 23.4 miles
WOODSTOCK, GA 30189
95 MORRISON MOORE PKWY W 23.9 miles
DAHLONEGA, GA 30533
6440 BELLS FERRY RD 23.9 miles
WOODSTOCK, GA 30189
199 MOUNTAIN DR STE 101 24.1 miles
DAHLONEGA, GA 30533
203 WOODPARK PL BLDG C 24.2 miles
WOODSTOCK, GA 30188
11780 NORTHFALL LN STE 301 24.5 miles
ALPHARETTA, GA 30009
1095 WOODSTOCK RD 24.6 miles
ROSWELL, GA 30075
11660 ALPHARETTA HWY, BLDG 700 24.6 miles
ROSWELL, GA 30076
3055 North Point Pkwy, Ste 300 24.7 miles
Alpharetta, GA 30005
1305 HEMBREE RD STE 103 24.9 miles
ROSWELL, GA 30076
(Don't see a location near you? Call us (800) 828-7086)
Local Area Info: DOTA-TATE
DOTA-TATE can be bound with radionuclides such as gallium-68 and lutetium-177 to form radiopharmaceuticals for PET imaging or radionuclide therapy. 177Lu DOTA-TATE therapy is a form of peptide receptor radionuclide therapy (PRRT) which targets somatostatin receptors (SSR). In that form of application it is a form of targeted drug delivery.
DOTA-TATE is a compound containing tyrosine3-octreotate, an SSR antagonist, and the bifunctional chelator (BFC) DOTA (tetraxentan). SSRs are found with high density in numerous malignancies, including CNS, breast, lung, and lymphatics. The role of SSR antagonists (i.e. somatostatin and its analogs such as octreotide, somatuline and vapreotide) in neuroendocrine tumours (NETs) is well established, and massive SSR overexpression is present in several NETs. (Tyr3)-octreotate binds the transmembrane receptors of NETs with highest activity for SSR2 and is actively transported into the cell via endocytosis, allowing trapping of the radioactivity and increasing the probability of the desired double-strand DNA breakage (for tumour control). Trapping improves the probability of this kind of effect due to the relatively short range of the beta particles emitted by 177Lu, which have a maximum range in tissue of <2 mm. Bystander effects include cellular damage by free radical formation.
68Ga DOTA-TATE (GaTate) is used to measure tumor SSR density and wholebody bio-distribution via PET imaging. 68Ga DOTA-TATE imagery has a much higher sensitivity and resolution compared to 111In octreotide gamma camera or SPECT scans, due to intrinsic modality differences.